DIRS.INFO The most relevant business & tech news

☆ The market is having knee-jerk reactions to Trump's picks. That could spell buying opportunities
▼ + stars: | 2024-11-21 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

Big swaths of the market have pulled back since the Nov. 5 election. Vaccine makers and processed food companies suffered after Robert F. Kennedy Jr., a prominent vaccine skeptic, was tapped to lead the Department of Health and Human Services. Just this week, HSBC upgraded Moderna to buy from hold, saying that its "pipeline deserves more than the market is giving it credit for." BioNTech, which pulled back more than 5% this month, was identified by Evercore ISI this week as a buying opportunity. AbbVie and First Solar are two other stocks with strong upside potential, based on analysts' consensus price targets compiled by FactSet.

Persons: Donald Trump's, Robert F, Kennedy Jr, Elon Musk, Vivek Ramaswamy, Nanette Abuhoff Jacobson, Luke O'Neill, FactSet Organizations: Department of Health, Human Services, Defense, Department of Government, Hartford Funds, Catalyst, Alpha Fund, White House, Moderna, HSBC, Evercore ISI, RFK Jr Locations: China

☆ Beware these stocks that rely on government spending if Musk’s DOGE threatens budgets
▼ + stars: | 2024-11-19 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Given this overhang, Morgan Stanley's sales team created a whole basket of stocks that have a large exposure to government spending. gov Relatively high revenue from government, as estimated by Morgan Stanley Notably, the list mostly excludes defense contractors, as Morgan Stanley expects them to be more insulated from budget cuts. Stocks in the basket include these 10: Moderna and Pfizer are two companies that made the basket. While the average analyst polled by LSEG has a hold rating, the average price target implies the stock will nearly double over the next year. MRNA PFE YTD mountain Moderna and Pfizer, year to date Research and consulting firm Gartner was also included in the Morgan Stanley basket.

Persons: Donald Trump's, Trump, Elon, Vivek Ramaswamy, it's, Morgan, Morgan Stanley, Trump's, Robert F, Kennedy Jr, LSEG, Gartner Organizations: Tesla, Roivant Sciences, Department of Government Efficiency, Intuit, Washington Post, Internal Revenue, gov, Moderna, Pfizer, Human Services, Research, Gartner Locations: Stamford , Connecticut

☆ How RFK Jr's war on obesity in the age of Ozempic could shake up the booming weight-loss industry
▼ + stars: | 2024-11-19 | by ( Rebecca Torrence | Hilary Brueck | ) www.businessinsider.com time to read: +9 min

Robert F. Kennedy Jr.'s proposed appointment to lead the US Department of Health and Human Services could have big consequences for a booming weight-loss market. AdvertisementHis likely appointment comes at a pivotal moment for the weight-loss industry, as long-lasting shortages of drugs like Ozempic come to an end. When Farmbox launched in 2014 to deliver healthy food boxes and educate consumers about nutrition, "nobody wanted to invest in us," Tyrner-Dolce said. Doug Mills-Pool/Getty ImagesKennedy's crusade against Big Food could run up against Trump's pro-corporation agenda, though. AdvertisementWeight-loss companies could get more attention — at a costKennedy's focus on holistic chronic disease care, including obesity care, could see a renewed funding rush to the space.

Persons: Trump, Robert F, Kennedy Jr, Kennedy, he's, Obama, Ashley Tyrner, Dolce, Farmbox, FarmboxRx, Michelle Obama, SAUL LOEB, Kennedy's, Jeff Nobbs, Nobbs, Doug Mills, Elon Musk, Donald Trump Jr, podcaster Joe Polish, Brooke Boyarsky Pratt, There's, Knownwell Pratt, Pratt, John Stanford Organizations: Human Services, US Department of Health, National Institutes of Health, Food and Drug Administration, Trump, Big Pharma, Senate, Novo Nordisk, Centers, Medicare, Services, Getty, Street, Department of Health, US Department of Agriculture, Shack, Business, Big Food, Trump's, KFC, McDonald's, Fox, FDA, Moderna Locations: Pennsylvania, Washington

☆ Cramer's Mad Dash: Moderna gets upgrade from HSBC
▼ + stars: | 2024-11-18 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCramer's Mad Dash: Moderna gets upgrade from HSBCCNBC's Jim Cramer reports on the latest news regarding Moderna.

Persons: HSBC CNBC's Jim Cramer Organizations: Moderna, HSBC CNBC's

☆ Stocks making the biggest moves midday: Moderna, Roku, CVS Health, Robinhood and more
▼ + stars: | 2024-11-18 | by ( Brian Evans | ) www.cnbc.com time to read: +3 min

Trump Media & Technology Group — Shares in President-elect Donald Trump's media company pulled back roughly 5%. Although the stock has been increasingly volatile in the wake of Trump's election, it has gained more than 52% in 2024. Redfin — The online real estate company's stock slipped 3.4% following a downgrade at Goldman Sachs to sell from neutral. CVS Health — Shares of the drugstore operator jumped nearly 6% following a decision to add four new board members in a deal with Glenview Capital. Moderna — Shares of the biotech company jumped more than 5% after HSBC upgraded the stock to buy from hold and said it views the stock as being undervalued.

Persons: Donald Trump's, Donald Trump, Chris Wright, Wright, Baird, Goldman Sachs, Wells, Needham, Piper Sandler, —, Alex Harring, Sean Conlon, Hakyung Kim, Pia Singh, Michelle Fox Organizations: Spirit Airlines —, Trump Media & Technology, Liberty Energy, Goldman, CVS, Glenview Capital, Aetna, U.S . Securities, Exchange, Nasdaq, Moderna —, HSBC, Warner Bros, —, National Basketball Association Locations: Wells Fargo

☆ Here are Monday's biggest analyst calls: Nvidia, Netflix, Tesla, Roku, Moderna, CVS, Alphabet, Robinhood & more
▼ + stars: | 2024-11-18 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Monday's biggest calls on Wall Street: Oppenheimer reiterates Netflix as outperform Oppenheimer said the Jake Paul-Mike Tyson fight "demonstrates [the] ability for meaningful" live event viewership for Netflix. Goldman Sachs initiates Ingram Micro as buy Goldman said the IT solutions provider is well positioned. Goldman Sachs initiates Gatx as buy Goldman said it's bullish on the railcar company. Baird upgrades Roku to outperform from neutral Baird said in its upgrade of Roku that it sees an "attractive long-term opportunity." Needham upgrades Robin Hood to buy from hold Needham said the stock is a beneficiary of the Trump election.

Persons: Oppenheimer, Jake Paul, Mike Tyson, it's bullish, Goldman Sachs, Ingram, Goldman, Baird, Morgan Stanley, Raymond James, Wells, Needham, Biogen, it's, Robin Hood, Trump, Donald Trump's, Bernstein, Tesla Organizations: Netflix, Citi, Astera, Ingram, GATX Corporation, RBC, UBS, Franco, Wheaton Precious Metals, WPM, HSBC, Moderna, Air Products, Hewlett Packard Enterprise, Enterprise, Aetna, Bank of America, Nvidia, " Bank of America, DOJ, Google, BMO, SEC, EV Locations: Nevada, Asia

☆ Stocks making the biggest moves premarket: Tesla, Nvidia, Robinhood, Liberty Energy and more
▼ + stars: | 2024-11-18 | by ( Hakyung Kim | In Hakyungkim | ) www.cnbc.com time to read: +3 min

Spirit Airlines — Shares of the struggling airline were halted on Monday after the company filed for bankruptcy protection . The stock rose 2.8% when trading resumed. Liberty Energy , Oklo — Shares of Liberty Energy rose 5% after Trump picked CEO Chris Wright as energy secretary . Robinhood — The electronic trading platform stock gained 1% after Needham upgraded shares to buy from hold. CVS Health — Shares of the drugstore company rose 2% following a Wells Fargo upgrade to overweight from equal weight.

Persons: Tesla, Donald Trump's, Chris Wright, Wright, Baird, Barron's, Needham, Robinhood, Robert F, Kennedy Jr, —, Sarah Min, Alex Harring, Jesse Pound, Spencer Kimball, Lisa Kailai Han Organizations: Bloomberg News, U.S . Transportation Department . Spirit Airlines, Liberty Energy, Oklo, of Liberty Energy, Trump, Nvidia, Blackwell, Nasdaq, Trump's Securities, Exchange Commission, CVS, Aetna, Warner Bros, National Basketball Association, Wall Street Journal, U.S, NBA, HSBC, Moderna Locations: Wells

Stocks tumbled on Friday as the post-election rally fizzled and investors fretted over the path of interest rates. The S&P 500 slipped 1.32% and closed at 5,870.62, while the Nasdaq Composite fell 2.24% to 18,680.12. Declines in pharmaceutical stocks weighed on the 30-stock Dow and broader S&P 500, with Amgen down about 4.2% and Moderna off by 7.3%. The information technology sector of the S&P 500 was the worst performing corner of the market, down more than 2% as Nvidia, MetaPlatforms, Alphabet and Microsoft tumbled. The S&P 500 posted a weekly loss of 2.1%, while the Nasdaq Composite slid about 3.2%.

Persons: Stocks, Donald Trump, Robert F, Kennedy Jr, Tesla, ”, Kristy Akullian, “, Jerome Powell, Susan Collins, Dow Jones Organizations: Dow Jones Industrial, Nasdaq, Dow, Moderna, Department of Health, Human Services, P Biotech, Nvidia, Microsoft, Trump Trade, ” Traders, Federal, Boston, Street Locations: Americas, BlackRock

☆ How we're thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS
▼ + stars: | 2024-11-15 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +7 min

Shares of obesity drugmaker Eli Lilly fell more than 4% on Friday, extending a roughly 3% slide in Thursday's session. Ozempic is the posterchild of the fast-growing GLP-1 class, in which Novo Nordisk and Eli Lilly are currently the two dominant players. Bottom line Eli Lilly has been our favorite drug stock for years thanks to its stellar pipeline led by GLP-1s. But, at this point, Kennedy's nomination requires us to be more cautious on Eli Lilly in the near term. Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.

Persons: Eli Lilly, Donald Trump, Robert F, Kennedy Jr, Kentucky Sen, Rand Paul, Kennedy, Trump, Eli Lilly's, John F, Kennedy —, LLY, Eli Lilly's GLP, Jim Cramer, David Ricks, Lilly, It's, Jim, it's, Jim Cramer's, Cristina Arias Organizations: Republican, Department of Health, Human Services, HHS, and Drug Administration, Centers for Disease Control, Medicare, Medicaid, Senate, Democratic, GOP, Media, Novo Nordisk, Moderna, Pfizer, Deutsche Bank, GSK, White, CDC, Street Journal, GLP, Big Pharma, FDA, tirzepatide, CNBC, Company, Pharmaceutical Locations: Washington, Kentucky, Danish, U.S, Alcobendas, Madrid, Spain

☆ Stocks making the biggest moves midday: Palantir, Moderna, Ulta Beauty, Alibaba and more
▼ + stars: | 2024-11-15 | by ( Pia Singh | In | ) www.cnbc.com time to read: +3 min

Global pharma stocks — Shares of several vaccine makers declined after President-elect Donald Trump selected prominent vaccine skeptic Robert F. Kennedy Jr. as health secretary on Thursday. Shares of Moderna and Pfizer slipped nearly 9% and 5%, respectively. Ulta slipped nearly 3% after Berkshire Hathaway revealed in a regulatory filing that it had sold around 97% of its shares, nearly dissolving its position in the beauty retailer. Berkshire had just bought the stock in the second quarter, making Ulta a relatively new bet. However, the company beat expectations on both lines in the fourth fiscal quarter and issued positive guidance for adjusted earnings per share.

Persons: Donald Trump, Robert F, Kennedy Jr, Eli Lilly, Warren Buffett, Berkshire Hathaway, Ulta, — CNBC's Sean Conlon, Alex Harring, Jesse Pound, Hakyung Kim, Lisa Han Organizations: Global pharma, Moderna, Pfizer, GSK, Novo Nordisk, Nasdaq, Securities and Exchange Commission, Super, New York Stock Exchange, Corp, Berkshire, Pool Corp, AST, Materials, LSEG Locations: China, Domino's, Berkshire

☆ Stocks making the biggest moves premarket: Alibaba, Applied Materials, Ulta Beauty and more
▼ + stars: | 2024-11-15 | by ( Hakyung Kim | In Hakyungkim | ) www.cnbc.com time to read: +2 min

Applied Materials — Shares tumbled more than 8% after the semiconductor equipment manufacturer offered weak revenue guidance for the current quarter. Applied Materials said it forecasts $7.15 billion in the first fiscal quarter, under the estimate of $7.224 billion from analysts polled by LSEG. Berkshire Hathaway bought more than 1.2 million shares, making the investment worth around $550 million at the end of September. Ulta Beauty – Shares slipped 5% after Berkshire Hathaway revealed in a regulatory filing that it had nearly dissolved its position in the beauty retailer, selling around 97% of its shares. Ulta was a new bet for Berkshire, which had just bought the stock in the second quarter.

Persons: Robert F, Kennedy Jr, Donald Trump's, Warren Buffett, Berkshire Hathaway, Ulta, Palantir, Jesse Pound, Lisa Kailai Han, Pia Singh Organizations: Materials, LSEG, Moderna, Department of Health, Human Services, Corp, —, Berkshire, Pool Corp, Nasdaq, New York Stock Exchange Locations: China, Domino's

☆ Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
▼ + stars: | 2024-11-15 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

Even with vaccine skeptic Robert F. Kennedy Jr. tapped to potentially lead the Department of Health and Human Services, CNBC's Jim Cramer said drug and junk food industries aren't necessarily headed for ruin. "Ultimately, if RFK dons jackboots and demands that we don't have vaccines or eat junk food, it probably won't matter," he said. At the same time, Cramer added, Kennedy has taken a hard stance against processed food. Many drug and processed food stocks have already shouldered heavy losses since Trump named Kennedy, including Eli Lilly , Bristol-Myers , Moderna , PepsiCo , J.M. Plus, he continued, drug and junk food stocks aren't particularly good investments during a rate-cutting cycle.

Persons: Robert F, Kennedy Jr, CNBC's Jim Cramer, Donald Trump, Kennedy, it's, Cramer, Kennedy's, Eli Lilly, Smucker, Mills, he's, Trump Organizations: Department of Health, Human Services, RFK, and Drug Administration, Centers for Disease Control, National Institutes of Health, HHS, Trump, Moderna, PepsiCo, J.M Locations: U.S, Bristol, Myers

☆ Wall Street looks for Nvidia to take the baton from election trades to keep rally alive in the week ahead
▼ + stars: | 2024-11-15 | by ( Sarah Min | ) www.cnbc.com time to read: +7 min

What exactly President-elect Donald Trump's second term means for the stock market will be the question investors continue to grapple with in the week ahead. Nvidia earnings results will also be on deck as investors deal with stubbornly high interest rates as well. The Dow Jones Industrial Average surged past 44,000 for the first time ever, and the S & P 500 and the Nasdaq Composite similarly posted new records. Sales of Blackwell and Grace Blackwell are expected to start to show up in results next year. The SPDR S & P Regional Banking ETF has surged 11% this month.

Persons: Donald Trump's, Jimmy Chang, Jensen Huang, CNBC's, Blackwell, Grace Blackwell, Harsh Kumar, Piper Sandler, Kumar, Jensen, Donald Trump, Robert F, Kennedy Jr, Novavax, Ken Mahoney, Trump, There's, Mahoney, Rockefeller's Chang, Chris Rupkey, Jerome Powell Organizations: Dow Jones, Nasdaq, Rockefeller Global Family, Treasury, Nvidia, Blackwell, Health, Human Services Department, Moderna, Asset Management, Regional Banking ETF, Federal, White, FWDBONDS, Housing, Walmart, Lowe's, Palo Alto Networks, Philadelphia Fed, . Kansas City Fed Manufacturing, Ross Stores, Intuit, Deere, PMI, PMI Manufacturing, PMI Services Locations: China, U.S, NAHB, . Kansas, Michigan

Shares of vaccine makers fell on Thursday as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human Services. Moderna’s stock closed more than 5% lower on Thursday, shares of Novavax fell more than 7% and Pfizer’s stock ended more than 2% lower. Shares of BioNTech, the German drugmaker that helped develop a Covid vaccine with Pfizer, closed more than 6% lower. Shares of those companies dipped further in extended trading as Trump confirmed his pick in a post on his platform Truth Social. Kennedy’s track record as a vaccine skeptic is extensive.

Persons: Donald Trump, Robert F, Kennedy Jr, Trump, Kennedy Organizations: Department of Health, Human Services, Pfizer, GSK, Health, Trump, Moderna, Health Defense Locations: Novavax, British, U.S

☆ Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary
▼ + stars: | 2024-11-14 | by ( Ramishah Maruf | ) edition.cnn.com time to read: +2 min

New York CNN —Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F. Kennedy Jr. to be the next secretary of the Department of Health and Human Services. An hour before the market closed Thursday, as news reports of Trump’s choice began trickling out, Covid-19 vaccine maker Moderna dipped as much as 6%, and Pfizer fell almost 2%. Novavax, which created a protein-based Covid-19 vaccine, fell almost 6%. Last week, Kennedy said he would “immediately” begin studying vaccine safety and efficacy but promised to not “take vaccines away from anybody.”Other vaccine-related companies also felt the fallout. Over the past year, Pfizer stock has dipped 11%, and Moderna stock has plunged 46%.

Persons: Donald Trump, Robert F, Kennedy Jr, Kennedy, “, Trump, ” Trump, CNN’s Kaitlan Collins, Kristen Holmes, Aaron Pellish Organizations: New, New York CNN, Department of Health, Human Services, Moderna, Pfizer, BioNTech, British GSK, Health, HHS Locations: New York, British

☆ Stocks making the biggest moves after hours: Domino's Pizza, Ulta, Applied Materials, Palantir and more
▼ + stars: | 2024-11-14 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Domino's Pizza , Ulta Beauty — Shares surged about 8% after Berkshire Hathaway announced a new stake in the pizza chain in a regulatory filling. The Warren Buffett-led firm bought more than 1.2 million shares, making the stake worth around $550 million at the end of September. Applied Materials — The semiconductor equipment manufacturer slid 5% after offering a weak revenue outlook for the current quarter. Applied Materials said to anticipate $7.15 billion in the first fiscal quarter, under the estimate of $7.224 billion from analysts polled by LSEG. Palantir will continue trading under the same ticker and expects to meet requirements to be listed in the Nasdaq 100 .

Persons: Berkshire Hathaway, Warren Buffett, Ulta, Despegar.com, FactSet, Robert F, Kennedy Jr, Donald Trump's Organizations: Berkshire, Materials, LSEG, Technologies, New York Stock Exchange, Nasdaq, Palantir, Department of Health, Human Services, Moderna, Pfizer Locations: Despegar.com —, Argentina

☆ Trump taps Robert F. Kennedy Jr. to lead Department of Health and Human Services
▼ + stars: | 2024-11-14 | by ( Alice Tecotzky | ) www.businessinsider.com time to read: +2 min

Trump has nominated Robert F. Kennedy Jr to lead the Department of Health and Human Services. The president-elect previously vowed to let Kennedy "go wild on health." AdvertisementTrump has nominated former presidential candidate Robert F. Kennedy Jr. to lead the Department of Health and Human Services, likely sparking a confirmation battle in the Senate. "I am thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of Health and Human Services (HHS)," Trump wrote on Truth Social. Representatives for Trump and Kennedy did not immediately respond to a request for comment.

Persons: Trump, Robert F, Kennedy Jr, Kennedy, —, Obama, Semafor Organizations: Department of Health, Human Services, Service, United, Health, Public Health, Biden, and Drug Administration, Pfizer, Moderna, Trump, HHS

☆ I grew my business to 7 figures after leaving Meta and Google. Here's the coffee chat formula that helped.
▼ + stars: | 2024-11-08 | by ( Andrew Yeung | ) www.businessinsider.com time to read: +7 min

Andrew Yeung, a former Google and Meta lead, goes on coffee chats three to five times a week. I spent a few years as a product lead at Google and a business operations lead at Meta before leaving to build a 7-figure business and invest in over 20 early-stage companies. Most of my business partnerships, clients, and — dare I say — friendships started with a coffee chat. Once I have clarity, I use my goal outcome to shape three discussion topics or broad questions for the conversation. Listen to learn, not to respondCome prepared to learn, but don't over-program your coffee chat.

Persons: Andrew Yeung, —, Kate Cronin, I've, would've Organizations: Google, Service, Meta Locations: Fibe

☆ Stocks making the biggest moves premarket: Lyft, SolarEdge, Qualcomm, Moderna and more
▼ + stars: | 2024-11-07 | by ( Brian Evans | ) www.cnbc.com time to read: +5 min

Lyft expects bookings in the current quarter of $4.28 billion to $4.35 billion, while analysts polled by FactSet expected $4.23 billion. SolarEdge — The solar panel inverter stock slipped more than 16% after a third-quarter revenue miss. SolarEdge reported revenue of $261 million, while analysts surveyed by LSEG were looking for $269 million. Third-quarter revenue surpassed Wall Street estimates, and the company expects fourth-quarter revenue of $256 million to $262 million, compared with an estimate of $260 million. Moderna — Shares rallied 7% after Moderna's third-quarter earnings and revenue topped expectations.

Persons: FactSet, SolarEdge, —, Zillow, Gilead, LSEG, Armour, Hershey, Samantha Subin, Hakyung Kim, Sarah Min Organizations: Arm, Wall, LSEG, FactSet, —, Qualcomm, Gilead Sciences, Hershey Locations: Gilead

☆ Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
▼ + stars: | 2024-11-07 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

Moderna on Thursday posted a surprise profit for the third quarter, smashing Wall Street estimates, as its cost-cutting efforts took hold and sales of its Covid vaccine came in higher than expected. Before year end, the company plans to file for approval of its experimental "next-generation" Covid vaccine and combination shot targeting Covid and the flu. Moderna this year also expects to apply for expanded approval of its RSV vaccine, targeting high-risk adults ages 18 to 59. "I think the earlier launch and a steeper ramp drove a much higher sales number" for the Covid vaccine, Moderna CEO Stéphane Bancel said in an interview. Analysts had expected sales of $132 million for the RSV vaccine, according to estimates compiled by StreetAccount.

Persons: Moderna, Stéphane Bancel, Bancel, StreetAccount, mull Organizations: Moderna, LSEG, Merck, Research Locations: U.S, Union, Norway, Iceland, Qatar, Europe

☆ Stock futures are little changed after major post-election rally as focus shifts to Fed: Live updates
▼ + stars: | 2024-11-06 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

US election news on a screen on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, Nov. 6, 2024. Stock futures are near flat Wednesday night after a huge market rally following Donald Trump's decisive victory in the presidential election. Futures tied to the Dow Jones Industrial Average added 25 points, or 0.1%. S&P 500 futures and Nasdaq 100 futures both traded marginally above flat. The Dow, S&P 500 and Nasdaq Composite all notched new all-time highs in the session, while the small cap-focused Russell 2000 jumped more than 5%.

Persons: Donald Trump's, Dow, Russell, Scott Helfstein, Jerome Powell's Organizations: New York Stock Exchange, Stock, Traders, Dow Jones, Nasdaq, U.S ., Global, CME Group's, Moderna, Warner Bros Locations: New York

Markets: The post-election rally on Wall Street continued into afternoon trading, with the Dow Jones Industrial Average jumping 3.4%, or roughly 1,450 points, and the S & P 500 advancing 2.4%. It's worth noting, the stock market was reacting like Jim Cramer said it would in his Sunday column . The one thing markets hate is uncertainty, and Wednesday's rally can be attributed, in part, to relief that Wall Street professionals and individual investors alike know where they stand and what to expect from the country's next president. Bond yields move inversely to prices, and a basis point is equal to 0.01%. "You have to be very careful to respect the bond market if you do any buying today," Jim said.

Persons: Jim Cramer, Donald Trump, Kamala Harris, Morgan Stanley, Jim, It's, Yun Li, Trump, Harris, Jerome Powell's, we'll, Jim Cramer's Organizations: CNBC, ., Wall, Dow Jones, Trump, Republican, NBC, Senate, NBC News, Wells, BlackRock, Energy, Coterra Energy, Honeywell, Federal, White, Arm Holdings, Qualcomm, Bros, Moderna, Barrick Gold, Halliburton, Hershey, Air Products, Chemicals, Warner Bros ., Jim Cramer's Charitable

☆ Trump says he will give RFK Jr. a major health role if he wins the White House. Here's what that means for patients, drugmakers
▼ + stars: | 2024-11-05 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +10 min

Some health experts said elevating Kennedy, even in an informal Trump administration position, could potentially lead to severe consequences for patients, drugmakers and the nation's public health overall. That could exacerbate the nation's existing public health challenges, such as declining childhood vaccination rates for several preventable diseases, some experts say. "I think we could reasonably predict that there would be a decline in vaccination rates among children, and perhaps vaccination overall." Drugmakers such as Pfizer and Moderna are still recovering from falling Covid vaccination rates in the U.S., which have dented their profits over the last two years. Kennedy's other proposals for overhauling federal health agencies will likely be difficult to execute.

Persons: Donald Trump, Robert F, Kennedy Jr, Anna Moneymaker, Kennedy, Trump, Dr, Paul Offit, Drew Altman, Altman, Genevieve Kanter, Cynthia Blancas, Deep Patel, Christina House, they've, Offit, Andrew Kelly, USC's Kanter, that's, Georges Benjamin, Covid, Kanter Organizations: Gas, Getty, White House, Trump, Children's Hospital of Philadelphia, CNBC, and Drug Administration, Centers for Disease Control, Commonwealth Fund, Senate, Washington Post, University of Southern, CVS, Los Angeles Times, CDC, Pfizer, Moderna, NBC, Health Defense, FDA, Department of Health, Human Services, U.S . Food, Drug Administration, Reuters, American Public Health Association, Pharma Locations: Duluth , Georgia, U.S, University of Southern California, Lynwood, Huntington Park, Samoa, White Oak , Maryland

In October, the Centers for Disease Control and Prevention recommended that high-risk adults get a second updated Covid vaccine to bolster their protection against the virus. No other vaccines are given at such a high frequency, but experts say there’s no reason to believe that the vaccines — and in particular, the mRNA vaccines from Pfizer and Moderna — aren’t effective. Pfizer’s and Moderna’s vaccines were the first to use mRNA technology to induce immunity to a virus, an approach that proved critical in the early days of the pandemic because mRNA vaccines can be developed much faster than traditional vaccines. Despite the CDC recommending an additional shot, there’s no evidence that the mRNA vaccines aren’t working as expected, said Akiko Iwasaki, a professor of immunology at the Yale School of Medicine. In a perfect world, the Covid vaccines would be able to be updated much faster to match the strains in circulation.

Persons: Akiko Iwasaki, Iwasaki, —, ”, Ashish Jha, ” Jha, “, Jha, I’ve, “ Topping, John Wherry, ” Wherry, Anna Durbin, ” Durkin, we’ll Organizations: Centers for Disease Control, Pfizer, Moderna, CDC, Yale School of Medicine, Emory University, Brown University School of Public Health, White, University of Pennsylvania, Johns Hopkins University School of Medicine

☆ Stock futures inch lower as Wall Street readies for U.S. presidential election: Live updates
▼ + stars: | 2024-11-03 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

Stock futures dipped in overnight trading Sunday as investors geared up for the highly-anticipated U.S. presidential election. S&P 500 futures and Nasdsq-100 futures edged lower. Stocks are coming off a strong start to November, with Amazon and big technology stocks boosting the tech-heavy Nasdaq Composite and S&P 500- 0.8% and 0.4%, respectively. Along with the election, Wall Street is bracing for the latest rate decision from the Federal Reserve. Earnings seasons presses on with about a fifth of the S&P 500 slated to report in the coming week.

Persons: —, Donald Trump, Kamala Harris, CFRA Research's Sam Stovall, CNBC's, We've, Jerome Powell, Sarah Min Organizations: Dow Jones Industrial, Amazon, Nasdaq, Dow Jones, NBC, U.S . House, Republican, Democratic, Federal Reserve, Traders, Micro, Moderna, CVS Health, Qualcomm, Wynn Resorts

Search resuls for: "modernă"

25 mentions found